HopeStage
Back to all studies
CompletedNCT01527448

Quetiapine for Postpartum Depression Related to Bipolarity

About this title

Quetiapine in the Treatment of Postpartum Depression (PPD) in Bipolar Disorder (BD), Type II

Read the official source — NCT01527448
Medication studyAges 19–40Canada
The study in practice

Understand this study

Who was this study for?

Listed age limits: 19 years to 40 years.

Listed locations
VancouverSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateApril 2008
Recruitment status
Completed
Enrollment listed in the registry
26
Sponsor
BC Women's Hospital & Health Centre
Sponsor type
Hospital / academic medical center
Study type
Drug
Intervention type
Drug
Locations
Canada
Age range
From 19 Years to 40 Years
Official registry ID
NCT01527448
Official title
Show the full official title

An Open Label Dose Titration Study of Quetiapine XR in the Treatment of Postpartum Depression in Nonlactating Women Diagnosed With Bipolar Disorder (BD), Type II.

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Vancouver

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is BC Women's Hospital & Health Centre, a hospital or academic medical center.

Did this study involve medication?

Yes. The study involved medication, including Quetiapine XR (seroquel).

Who was this study for?

Listed age limits: 19 years to 40 years.

Want to explore more studies?

Explore studies